According to the study, the global pharmaceutical filtration market is likely to grow significantly during the forecast period, due to increasing prevalence of chronic diseases, rising prevalence of cancer, increasing geriatric population and increasing production of biopharmaceuticals and generic drugs. In addition, rising healthcare expenditure leading to increase in research and development spending also contributes to the growth of the overall market. High cost of pharmaceutical filtration and stringent regulatory requirements for validation of filtration process are the key factors restraining the global market growth.
Insights on market segments
As per the findings of the research, the membrane filter is the largest product category in the global pharmaceutical filtration market. Membrane filter is the microporous film with specific pore size, used for retaining unwanted particles or microorganisms larger than their pore size. Microfiltration has been the largest contributor to the growth of the global market, in terms of revenue, among the various techniques for product filtration. Final product processing has been the largest application area for pharmaceutical filtration, followed by raw material filtration, cell separation, water purification and air purification. Manufacturing-scale of operation has been the largest segment of the global market, based on scale of operation.
North America stands as the largest pharmaceutical filtration market
Geographically, North America has been the largest market for pharmaceutical filtration, with the U.S. being the larger contributor to the regional market, compared to Canada. Increasing prevalence of lifestyle associated and chronic diseases, rising geriatric population and increasing production of biopharmaceuticals are the factors that have been driving the growth of the North American market for pharmaceutical filtration. The U.K. has been the largest contributor to the European market for pharmaceutical filtration, followed by Germany and France. The market is expected to witness the fastest growth in Asia-Pacific during 2017 - 2023, owing to increasing cases of chronic diseases, increasing healthcare expenditure leading to increasing research and development spending and increasing geriatric population.
Increasing prevalence of chronic diseases largely impacts the market
Globally, the increasing prevalence of chronic diseases has been playing a key role in the growth of the pharmaceutical filtration market. The rapidly increasing burden of chronic diseases further compels government organizations and healthcare providers to provide improved facilities for effective disease treatment leading to increased drug launch globally.
Prevalence of chronic diseases is increasing due to alteration in lifestyle and lack of access to preventive care. According to the Centers for Disease Control and Prevention (CDC), in 2012, approximately 117 million people in the U.S. had one or more chronic health conditions. The organization also reported that during 2013 – 2015, 54.4 million U.S. adults were diagnosed with some form of arthritis, rheumatoid arthritis, gout, lupus or fibromyalgia. Moreover, an estimated 78 million Americans aged 18 years or above will be diagnosed with arthritis by 2040.
According to the International Agency for Research on Cancer (IARC), a specialized cancer agency of World Health Organization (WHO) that promotes cancer research, 12.7 million new patients globally were detected with cancer in 2008, and the number is expected to reach 21.4 million by 2030. In addition, according to the WHO, 8.2 million deaths took place globally due to cancer in 2012, out of which 1.6 million were due to lung cancer, while 745,000 deaths resulted from liver cancer and 400,000 deaths were an outcome of esophageal cancer.
The increasing burden of chronic diseases is expected to result in higher death rates and additional economic cost. Thus, several developments have been taking place for efficient disease treatment, leading to increased production of drugs supporting the growth of the pharmaceutical filtration market globally.
Key players in the pharmaceutical filtration market
Some of the key players in the global pharmaceutical filtration market include Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd. and Meissner Filtration Products, Inc. GLOBAL PHARMACEUTICAL FILTRATION MARKET SEGMENTATION
Microfiltration Ultrafiltration Nanofiltration Others By Application
Final Product Processing Active Pharmaceutical Ingredient Filtration Sterile Filtration Protein Purification Vaccine and Antibody Processing Formulation and Filling Solution Filtration Viral Clearance Raw Material Filtration Media and Buffer Filtration Prefiltration Bioburden Testing Cell Separation Water Purification Air Purification By Scale of Operations
Manufacturing-Scale Pilot-Scale R&D-Scale By Geography
North America The U.S. Canada Europe The U.K. Germany France Italy Spain Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific Latin America Brazil Mexico Rest of Latin America Middle East and Africa
Our reports have been used by over 10K customers, including:
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations...
The global breakfast food market exhibited moderate growth during 2015-2020. Breakfast food refers to various products that are consumed as the first meal of the day. Some of the most common types of breakfast foods include cereals, bread, eggs, porridge, waffles, pancakes, snack bars, bacon and sausages. They are majorly...
Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 Summary Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Anemia of Chronic Disease pipeline landscape. The report provides comprehensive information...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
175 pages •
By The Business Research Company
• Jul 2021
Major players in the live cell imaging market are Leica Microsystems, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare, Carl Zeiss Meditec AG, Becton Dickinson and Company, Molecular Devices LLC, Bruker Corporation, Sartorius AG, Oxford Instruments, BioTek Instruments, Etaluma Inc, and CytoSMART Technologies. The...
120 pages •
By Infiniti Research Limited
• Jun 2021
Global Biochip Market 2021-2025 The analyst has been monitoring the biochip market and it is poised to grow by $ 25.52 bn during 2021-2025, progressing at a CAGR of almost 23% during the forecast period. Our report on biochip market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges,...
175 pages •
By The Business Research Company
• Jun 2021
Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, Glaxosmithkline, Pfizer, Boehringer Ingelheim, and F. Hoffmann-La Roche. The global protein inhibitors market is expected to grow from $56.97 billion in 2020 to $62.54 billion in 2021 at a compound annual growth rate (CAGR) of 9.8%....
U.S. Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Delivery Type (Web-based, Cloud-based, On-premise), By Component, By End Use, By Application, By Therapeutic Area, And Segment Forecasts, 2021 - 2028
U.S. Patient Engagement Solutions Market Growth & Trends
KEY FINDINGS The global biosurgery market is forecasted to record a CAGR of 6.32% during the projected period of 2021 to 2028. The market growth is attributed to the rising geriatric population, the incidence of musculoskeletal disorders, technological advancements, and the increasing research and development endeavors. MARKET...
The global hyperspectral imaging systems market exhibited strong growth during 2015-2020. A hyperspectral imaging system can be defined as a technique used to analyze a wide spectrum of light through a spectrometer. The device uses reflected, transferred or emitted light from the object to generate its spectral-based...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.